
Keywords: AD; Alzheimer's disease; BBB; blood brain barrier; IL; interleukin; IκB; inhibitor of nuclear factor of kappa light polypeptide gene enhancer in B-cells; NF-κB; nuclear factor kappa-light-chain-enhancer of activated B-cells; POCD; postoperative cognitiv